Last reviewed · How we verify
Chloromycetin — Competitive Intelligence Brief
marketed
Amphenicol-class Antibacterial
Infectious Disease
Live · refreshed every 30 min
Target snapshot
Chloromycetin (chloramphenicol succinate) — Parkedale.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Chloromycetin TARGET | chloramphenicol succinate | Parkedale | marketed | Amphenicol-class Antibacterial | 1950-01-01 | |
| Chlorocidin | CHLORAMPHENICOL | Parkedale | marketed | Amphenicol-class Antibacterial | Cytochrome P450 3A4 | 1950-01-01 |
| Chloromycetin Palmitate | chloramphenicol palmitate | marketed | Amphenicol-class Antibacterial |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Amphenicol-class Antibacterial class)
- Parkedale · 2 drugs in this class
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Chloromycetin CI watch — RSS
- Chloromycetin CI watch — Atom
- Chloromycetin CI watch — JSON
- Chloromycetin alone — RSS
- Whole Amphenicol-class Antibacterial class — RSS
Cite this brief
Drug Landscape (2026). Chloromycetin — Competitive Intelligence Brief. https://druglandscape.com/ci/chloramphenicol-succinate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab